Cargando…

Measurement properties of the EQ-5D-5L and PROPr in patients with spinal muscular atrophy

OBJECTIVES: Spinal muscular atrophy (SMA) is a rare monogenic neuromuscular disorder caused by loss of function mutations. Measuring health-related quality of life to support economic evaluations in this population is encouraged. However, empirical evidence on the performance of preference-based mea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Richard Huan, Ma, Bin, Xin, Huanping, Zhang, Huanyu, Zeng, Yan, Luo, Nan, Dong, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647137/ https://www.ncbi.nlm.nih.gov/pubmed/37968716 http://dx.doi.org/10.1186/s12955-023-02204-z

Ejemplares similares

A Comparison of PROPr and EQ-5D-5L Value Sets
por: Pan, Tianxin, et al.
Publicado: (2021)

Understanding the measurement relationship between EQ-5D-5L, PROMIS-29 and PROPr
por: Mulhern, Brendan J., et al.
Publicado: (2023)

Scale agreement, ceiling and floor effects, construct validity, and relative efficiency of the PROPr and EQ-5D-3L in low back pain patients
por: Klapproth, Christoph Paul, et al.
Publicado: (2023)

Investigating the Added Value of the EQ-5D-5L With Two Bolt-On Items in Patients With Hemophilia
por: Xu, Richard Huan, et al.
Publicado: (2021)

Comparing the performance of the EQ-5D-3 L and the EQ-5D-5 L in an elderly Chinese population
por: You, Ruxu, et al.
Publicado: (2020)

Les salles propres
por: Whyte, William, et al.
Publicado: (2001)

Production ultra propre
por: Morvan, Gilles
Publicado: (2011)

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
por: Pattanaphesaj, Juntana, et al.
Publicado: (2015)

Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran
por: Moradi, Nasrin, et al.
Publicado: (2022)

Valuation of the EQ-5D-5L in Taiwan
por: Lin, Hsiang-Wen, et al.
Publicado: (2018)

Patient-caregiver agreement and test–retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies
por: Zhou, Wenjing, et al.
Publicado: (2021)

Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease
por: Liu, Xiaodong, et al.
Publicado: (2023)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

An EQ-5D-5L Value Set for Vietnam
por: Mai, Vu Quynh, et al.
Publicado: (2020)

Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients
por: Fitriana, Titi Sahidah, et al.
Publicado: (2021)

Nusinersen: A Review in 5q Spinal Muscular Atrophy
por: Hoy, Sheridan M.
Publicado: (2021)

Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
por: Olariu, Elena, et al.
Publicado: (2023)

Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis
por: Koszorú, Kamilla, et al.
Publicado: (2022)

EQ-5D-5L norms for the urban Chinese population in China
por: Yang, Zhihao, et al.
Publicado: (2018)

Cross-cultural measurement equivalence of the 5-level EQ-5D (EQ-5D-5L) in patients with type 2 diabetes mellitus in Singapore
por: Wang, Ye, et al.
Publicado: (2015)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Health‐related quality of life in patients with multiple system atrophy using the EQ‐5D‐5L
por: Xiao, Yi, et al.
Publicado: (2022)

Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries
por: Janssen, Mathieu F., et al.
Publicado: (2018)

Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
por: Hoy, Sheridan M.
Publicado: (2021)

Antibioprophylaxie dans les chirurgies gynécologiques et obstétricales propres et propres contaminées à l'Hôpital Général de Yaoundé, Cameroun
por: Ngowa, Jean Dupont Kemfang, et al.
Publicado: (2014)

Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults
por: Ferreira, Lara N., et al.
Publicado: (2016)

Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values
por: Selivanova, Anna, et al.
Publicado: (2018)

Estimating the EQ-5D-5L value set for the Philippines
por: Miguel, Red Thaddeus D., et al.
Publicado: (2022)

EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets
por: Jiang, Ruixuan, et al.
Publicado: (2022)

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study
por: Janssen, M. F., et al.
Publicado: (2012)

Psychometric Properties of the Spanish Versions of EQ-5D-Y-3L and EQ-5D-Y-5L in Children with Cancer: A Comparative Study
por: Perez-Sousa, Miguel A., et al.
Publicado: (2022)

Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
por: Bató, Alex, et al.
Publicado: (2021)

Nusinersen Wearing-Off in Adult 5q-Spinal Muscular Atrophy Patients
por: Osmanovic, Alma, et al.
Publicado: (2021)

Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
por: Osmanovic, Alma, et al.
Publicado: (2021)

Cognitive Impairment in Adult Patients with 5q-Associated Spinal Muscular Atrophy
por: Kizina, Kathrin, et al.
Publicado: (2021)

Biomarkers in 5q-associated spinal muscular atrophy—a narrative review
por: Lapp, H. S., et al.
Publicado: (2023)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_931ghjv9nrn6eo6v69oev8kgct